Clinical Comparison with Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions

American Journal of Cardiology

Volumn 116, Issue 5, 2015, Pages 705-710

  Cortese, Bernardo ^a   Ielasi, Alfonso ^b   Romagnoli, Enrico ^b   Varricchio, Attilio ^c   Cuculo, Andrea ^d   Loi, Bruno ^e   Pisano, Francesco ^f   Corrado, Donatella ^g   Sesana, Marco ^b   La Vecchia, Luigi ^h   Summaria, Francesco ⁱ   Tespili, Maurizio ^b   Silva Orrego, Pedro ^a   Tognoni, Gianni ^g   Steffenino, Giuseppe ^b  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b AO Bolognini ^*  (Italy)

^c MONALDI HOSPITAL   (Italy)

^d Division of Nephrology Dialysis and Transplantation   (Italy)

^e BROTZU HOSPITAL   (Italy)

^f Ospedale Regionale U Parini   (Italy)

^g MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^h SAN BORTOLO HOSPITAL   (Italy)

ⁱ Casilino Clinic   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; HIRULOG; PRASUGREL; TICAGRELOR; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ADULT; AGED; ARTICLE; BIORESORBABLE SCAFFOLD; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY STENTING; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; SURGICAL RISK; TARGET LESION REVASCULARIZATION; TREATMENT DURATION; ANALOGS AND DERIVATIVES; ANGIOCARDIOGRAPHY; BIODEGRADABLE IMPLANT; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY; INCIDENCE; ITALY; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROSTHESIS; RANDOMIZED CONTROLLED TRIAL; TIME; TISSUE SCAFFOLD; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; AGED; ANTINEOPLASTIC AGENTS; CORONARY ANGIOGRAPHY; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; EVEROLIMUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SIROLIMUS; TIME FACTORS; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 84952872485     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.05.049     Document Type: Article

References (21)

1. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) P.G. Steg, S.K. James, D. Atar, L.P. Badano, C. Blömstrom-Lundqvist, M.A. Borger, C. Di Mario, K. Dickstein, G. Ducrocq, F. Fernandez-Aviles, A.H. Gershlick, P. Giannuzzi, S. Halvorsen, K. Huber, P. Juni, A. Kastrati, J. Knuuti, M.J. Lenzen, K.W. Mahaffey, M. Valgimigli, A. van 't Hof, P. Widimsky, and D. Zahger ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
2. G. Montalescot, S.D. Wiviott, E. Braunwald, S.A. Murphy, C.M. Gibson, C.H. McCabe, E.M. Antman TRITON-TIMI 38 investigators Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731
3. P.G. Steg, S. James, R.A. Harrington, D. Ardissino, R.C. Becker, C.P. Cannon, H. Emanuelsson, A. Finkelstein, S. Husted, H. Katus, J. Kilhamn, S. Olofsson, R.F. Storey, W.D. Weaver, L. Wallentin PLATO Study Group Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis Circulation 122 2010 2131 2141
4. D.J. Kumbhani, A.A. Bavry, M.Y. Desai, S. Bangalore, and D.L. Bhatt Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials J Am Coll Cardiol 62 2013 1409 1418
5. T. Palmerini, G. Biondi-Zoccai, D. Riva Della, A. Mariani, M. Sabaté, M. Valgimigli, G. Frati, E. Kedhi, P.C. Smits, C. Kaiser, P. Généreux, S. Galatius, A.J. Kirtane, and G.W. Stone Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis J Am Coll Cardiol 62 2013 496 504
6. S. Bangalore, N. Amoroso, M. Fusaro, S. Kumar, and F. Feit Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials Circ Cardiovasc Interv 6 2013 378 390
7. R. Diletti, T. Yetgin, O.C. Manintveld, J.M. Ligthart, C. Zivelonghi, F. Zijlstra, and F. Ribichini Percutaneous coronary interventions during ST-segment elevation myocardial infarction: current status and future perspectives EuroIntervention 10 Suppl T 2014 T13 T22
8. Y. Onuma, and P.W. Serruys Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 123 2011 779 797
9. P.W. Serruys, H.M. Garcia-Garcia, and Y. Onuma From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J 33 2012 16 25b
10. A. Ielasi, B. Cortese, A. Varricchio, M. Tespili, M. Sesana, F. Pisano, B. Loi, F. Granata, E. Moscarella, P. Silva-Orrego, L. La Vecchia, and G. Steffenino Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre "Registro ABSORB Italiano" (RAI registry) EuroIntervention 2015 (in press) Doi:10.4244/EIJY14M10-11
11. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.-A. van Es, P.G. Steg, M.-A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
12. R.J. Little, and D.B. Rubin Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches Annu Rev Public Health 21 2000 121 145
13. T. Gori, E. Schulz, U. Hink, P. Wenzel, F. Post, A. Jabs, and T. Münzel Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes EuroIntervention 9 2014 1036 1041
14. D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry EuroIntervention 10 2015 1144 1153
15. R. Diletti, A. Karanasos, T. Muramatsu, S. Nakatani, N.M. Van Mieghem, Y. Onuma, S.T. Nauta, Y. Ishibashi, M.J. Lenzen, J. Ligthart, C. Schultz, E. Regar, P.P. de Jaegere, P.W. Serruys, F. Zijlstra, and R.J. van Geuns Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study Eur Heart J 35 2014 777 786
16. V. Kočka, M. Malý, P. Toušek, T. Buděšínský, L. Lisa, P. Prodanov, J. Jarkovský, and P. Widimsky Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19' Eur Heart J 35 2014 787 794
17. M. Sabaté, A. Cequier, A. Iñiguez, A. Serra, R. Hernandez-Antolin, V. Mainar, M. Valgimigli, M. Tespili, P. Heijer den, A. Bethencourt, N. Vazquez, J.A. Gómez-Hospital, J.A. Baz, V. Martín-Yuste, R.J. van Geuns, F. Alfonso, P. Bordes, M. Tebaldi, M. Masotti, A. Silvestro, B. Backx, S. Brugaletta, G.A. van Es, and P.W. Serruys Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial Lancet 380 2012 1482 1490
18. S. Brugaletta, T. Gori, A.F. Low, P. Toušek, E. Pinar, J. Gomez-Lara, G. Scalone, E. Schulz, M.Y. Chan, V. Kočka, J. Hurtado, J.A. Gomez-Hospital, T. Münzel, C.-H. Lee, A. Cequier, M. Valdés, P. Widimsky, P.W. Serruys, and M. Sabaté Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-Year results of a propensity score matching comparison: the BVS-EXAMINATION study (Bioresorbable vascular scaffold - A clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction) JACC Cardiovasc Interv 8 2015 189 197
19. D. Dudek, Y. Onuma, J.A. Ormiston, L. Thuesen, K. Miquel-Hebert, and P.W. Serruys Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial EuroIntervention 7 2012 1060 1061
20. P.W. Serruys, B. Chevalier, D. Dudek, A. Cequier, D. Carrié, A. Iñiguez, M. Dominici, R.J. van der Schaaf, M. Haude, L. Wasungu, S. Veldhof, L. Peng, P. Staehr, M.J. Grundeken, Y. Ishibashi, H.M. Garcia-Garcia, and Y. Onuma A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial Lancet 385 2014 43 54
21. R.P. Kraak, M.E. Hassell, M.J. Grundeken, K.T. Koch, J.P. Henriques, J.J. Piek, J. Baan, M.M. Vis, E.K. Arkenbout, J.G. Tijssen, R.J. de Winter, and J.J. Wykrzykowska Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry EuroIntervention 10 2015 1160 1168